Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Åke Lernmark

Principal investigator

Default user image.

Next generation sequencing reveals that HLA-DRB3, -DRB4 and -DRB5 may be associated with islet autoantibodies and risk for childhood type 1 diabetes.

Author

  • Lue Ping Zhao
  • Shehab Alshiekh
  • Annelie Carlsson
  • Helena Larsson
  • Gun Forsander
  • Sten Ivarsson
  • Johnny Ludvigsson
  • Ingrid Kockum
  • Claude Marcus
  • Martina Persson
  • Ulf Samuelsson
  • Eva Örtqvist
  • Chul-Woo Pyo
  • Wyatt C Nelson
  • Daniel E Geraghty
  • Åke Lernmark

Summary, in English

The possible contribution of HLA-DRB3, -DRB4 and -DRB5 alleles to type 1 diabetes risk and to autoantibodies against insulin (IAA), GAD65 (GADA), IA-2 (IA-2A) or ZnT8 against either of the three amino acid variants, R, W or Q at position 325 (ZnT8RA, ZnT8WA, and ZnT8QA, respectively) at clinical diagnosis is unclear. Next generation sequencing (NGS) was therefore used to determine all DRB alleles in consecutively diagnosed, islet autoantibody positive 1-18 years old type 1 diabetes patients (n=970) and controls (n=448). It was tested whether DRB3, DRB4 or DRB5 alleles were associated with the risk of DRB1 for autoantibodies, type 1 diabetes, or both. The association between type 1 diabetes and DRB1*03:01:01 was affected by DRB3*01:01:02 and DRB3*02:02:01. These DRB3 alleles were associated positively with GADA but negatively with ZnT8WA, IA-2A and IAA. The negative association between type 1 diabetes and DRB1*13:01:01 was affected by DRB3*01:01:02 to increase the risk and by DRB3*02:02:01 to maintain a negative association. DRB4*01:03:01 was strongly associated with type 1 diabetes (p=10(-36)) yet its association was extensively affected by DRB1 alleles from protective (DRB1*04:03:01) to high (DRB1*04:01:01) risk but with DRB1:04:05:01 it decreased the risk. HLA-DRB3, -DRB4, and -DRB5 affect type 1 diabetes risk and islet autoantibodies. HLA typing with next generation sequencing should prove useful to select participants for prevention or intervention trials.

Department/s

  • Diabetes and Celiac Unit
  • Paediatrics (Lund)
  • Paediatric Endocrinology
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year

2016-01-06

Language

English

Pages

710-718

Publication/Series

Diabetes

Volume

65

Issue

3

Document type

Journal article

Publisher

American Diabetes Association Inc.

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Diabetes and Celiac Unit
  • Paediatric Endocrinology

ISBN/ISSN/Other

  • ISSN: 1939-327X